Utah Medical Products
UTMD
UTMD
110 hedge funds and large institutions have $123M invested in Utah Medical Products in 2025 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 39 increasing their positions, 37 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
110
Holders Change
+2
Holders Change %
+1.85%
% of All Funds
1.47%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
16
Increased
39
Reduced
37
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$1.84M |
| 2 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$1.65M |
| 3 |
BlackRock
New York
|
+$1.07M |
| 4 |
HCM
Huber Capital Management
El Segundo,
California
|
+$884K |
| 5 |
QCM
Quantinno Capital Management
New York
|
+$608K |
Top Sellers
| 1 |
JPMorgan Chase & Co
New York
|
-$3.77M |
| 2 |
RA
Royce & Associates
New York
|
-$2.35M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$941K |
| 4 |
Two Sigma Investments
New York
|
-$773K |
| 5 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$735K |
